共 9 条
[1]
Conversion of Recent onset paroxysmal atrial fibrillation to normal sinus rhythm: The effect of no treatment and high-dose amiodarone. Cotter G,Blatt A,Kaluski E,et al. European Heart Journal . 1999
[2]
Placebo-controlled randomized trial of warfarin and Aspirin for prevention of thromboembolic complications in chronic atrial fibrillation.The Copenhagen AFASAK study. Deterson P,Boysen G,Godtfredsen J,et al. The Lancet . 1989
[3]
Prevalence, age,distribution and gender of patients with atrial fibrillation. Feinberg WM,Blackshear JL,Laupacis A,et al. Archives of Internal Medicine . 1995
[4]
The risk for and severity of bleeding complications in elderly patients treated with warfarin. fihn SD,Callahan CM,Martin DC,et al. Annals of Internal Medicine . 1996
[5]
The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the manitoba follow-up study. Krahn AD,Manfreda J,Tate RB,et al. The American Journal of Medicine . 1995
[6]
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Fuster V,Ryden LE. Journalism Assn of Community College . 2001
[7]
Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. Brannwald E. The New England Journal of Medicine . 1997
[8]
Assessment of atrioventricular function ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Brignole M,Gianfranchi L,Menozzi C,et al. Circulation . 1997
[9]
Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. Pearce LA,Hart RG,Halperin JL. The American Journal of Medicine . 2000